Família Methotrexate

Methotrexate · class III · Until 21/10/2034

Registration no.
10287411705
Process no.
25351342584202414
Status
Until 21/10/2034
Device type
Methotrexate (METOTREXATE)
Risk class
III
Registration holder
ROCHE DIAGNÓSTICA BRASIL LTDA CNPJ 30.280.358/0001-86 · 1,784 registrations
Manufacturer
ROCHE DIAGNOSTICS GMBH · Germany
Published
21/10/2024
Valid until
21/10/2034
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other methotrexate registrations (8 in total, see all)

ProductClass HolderPublishedStatus
Metotrexato (MTX) - SNIBE
10303460618
III IN VITRO DIAGNOSTICA LTDA 24/08/2026 Until 24/08/2036
Família Alinity i Methotrexate
80146502269
III ABBOTT LABORATORIOS DO BRASIL LTDA 03/08/2020 Until 03/08/2030
ARCHITECT Methotrexate Extended Range Controls
80146501930
III ABBOTT LABORATORIOS DO BRASIL LTDA 01/06/2015 Until 01/06/2035
ARCHITECT Methotrexate Controls
80146501928
III ABBOTT LABORATORIOS DO BRASIL LTDA 11/05/2015 Until 11/05/2035
ARCHITECT Methotrexate Calibrators
80146501929
III ABBOTT LABORATORIOS DO BRASIL LTDA 11/05/2015 Until 11/05/2035
ARCHITECT Methotrexate Reagent Kit
80146501923
III ABBOTT LABORATORIOS DO BRASIL LTDA 16/03/2015 Until 16/03/2035
EMIT - ENSAIO DE METOTREXATO
10345161293
III SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA 10/08/2009 Until 06/10/2033